Jaumot Frank E 4

What Happened
Frank E. Jaumot, a director of Nutex Health, was granted 823 restricted stock units (RSUs) on April 23, 2026. The Form 4 records the award as 823 units acquired at $0.00 (derivative award); no cash changed hands. The RSUs convert into one share of Nutex Health common stock per unit upon vesting.

Key Details

• Transaction date: April 23, 2026; Form 4 filed April 24, 2026 (timely filing).
• Transaction type/code: Grant of RSUs (code A on Form 4); 823 units @ $0.00.
• Vesting: 100% vests on April 23, 2027. If the director leaves without cause during the vesting period, the RSUs vest pro-rata for time served.
• Footnotes: Each RSU equals a contingent right to one share at vesting; the grant and vesting terms are described in the filing.
• Shares owned after transaction: Not specified in the provided filing details.

Context
RSUs are a form of equity compensation that become actual shares only if and when they vest; this is a derivative award rather than an open-market purchase or sale. Director RSU grants are common as compensation and do not by themselves indicate a buy or sell decision in the market until they vest and (if) shares are received or sold.